Switch From Mounjaro to Wegovy UK - Cheapest Price £124.99

Clinically Proven UK Registered Pharmacy

Cheapest Switch Mounjaro to Wegovy UK - From £124.99

Switch from Mounjaro to Wegovy at the cheapest UK price from £124.99 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

How to Switch From Mounjaro to Wegovy: UK Clinical Guidance

Many patients consider whether to switch from Mounjaro to Wegovy when managing their weight loss journey, often due to supply availability, cost considerations, or individual response to treatment. Both medications belong to the GLP-1 receptor agonist class but contain different active ingredients—tirzepatide in Mounjaro and semaglutide in Wegovy—each with distinct dosing schedules and clinical profiles. Understanding the transition process, dose equivalence, and what to expect during the switch is essential for maintaining safe and effective weight management under UK prescriber supervision.

Why Patients Switch From Mounjaro to Wegovy in the UK

The decision to switch from Mounjaro to Wegovy typically arises from several practical and clinical factors. Supply chain disruptions have periodically affected both medications across UK pharmacies, prompting patients and prescribers to consider alternatives to maintain continuity of care. Cost differences also play a significant role—whilst Mounjaro is priced from £124.99 at Cured Pharmacy, Wegovy starts from £124.99, yet individual insurance coverage or personal budgets may favour one over the other depending on specific circumstances[1].

Clinical response varies between individuals, and some patients find that switching from Mounjaro to Wegovy better suits their tolerance profile or weight loss trajectory. Mounjaro's dual GIP/GLP-1 receptor agonism produced an average weight reduction of 15-22.5% in the SURPASS-1 trial, whilst Wegovy's semaglutide achieved 14.9% average weight loss in the STEP 1 trial[2]. Prescribers may recommend a switch if side effects prove more manageable on one medication, or if plateau effects suggest benefit from changing the therapeutic mechanism. All switches require clinical assessment by a UK-registered prescriber to ensure safety and appropriateness for the individual patient.

Dose Equivalence When You Switch From Mounjaro to Wegovy

Understanding dose equivalence is critical when planning to switch from Mounjaro to Wegovy, as the two medications follow different titration schedules and mg-for-mg dosing is not directly comparable. Mounjaro uses a four-week escalation starting at 2.5mg weekly, increasing through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum maintenance dose of 15mg. Wegovy begins at 0.25mg weekly, doubling every four weeks through 0.5mg, 1mg, 1.7mg, to a maintenance dose of 2.4mg[3].

UK prescribers typically assess the patient's current Mounjaro dose and weight loss response to determine the appropriate Wegovy starting point. A patient stable on Mounjaro 5mg may transition to Wegovy 1mg or 1.7mg depending on tolerability and efficacy observed during their tirzepatide treatment. There is no universally agreed conversion chart, as individual response, side effect history, and clinical goals guide the decision. The switch from Mounjaro to Wegovy should involve a brief washout period or direct crossover as determined by the prescriber, with close monitoring during the first four weeks to assess gastrointestinal tolerance and glycaemic effects where relevant.

Recommended Transition Protocol

Most UK clinicians recommend administering the first Wegovy dose one week after the final Mounjaro injection to allow clearance of tirzepatide, which has a half-life of approximately five days. Starting Wegovy at a lower dose than the equivalent Mounjaro strength reduces the risk of overlapping GLP-1 effects and minimises nausea or gastrointestinal discomfort. Patients should report any significant side effects or lack of appetite control during the transition, as dose adjustments may be required to optimise outcomes when switching from Mounjaro to Wegovy.

What to Expect During the Switch From Mounjaro to Wegovy

Patients switching from Mounjaro to Wegovy commonly experience a brief adjustment period as the body adapts to the new medication's pharmacokinetics and receptor activity profile. Gastrointestinal side effects—nausea, constipation, diarrhoea—may re-emerge or change in intensity, even if previously well-tolerated on Mounjaro. Semaglutide's longer half-life (approximately seven days) means steady-state concentrations build gradually, and full appetite suppression may take two to three weeks to match prior Mounjaro effects[4].

Weight loss trajectory may plateau temporarily during the switch from Mounjaro to Wegovy as the body recalibrates to the different GLP-1 agonist. Clinical experience shows most patients resume consistent weight reduction within four to six weeks, provided adherence to the prescribed dose schedule and lifestyle modifications continue. Blood glucose levels in patients with type 2 diabetes should be monitored closely during the transition, as the shift from dual GIP/GLP-1 agonism to pure GLP-1 agonism can subtly alter glycaemic control. UK prescribers at Cured Pharmacy provide ongoing support throughout the switching process, with follow-up consultations available to address any concerns or adjust dosing as clinically indicated.

Managing Side Effects During Transition

To minimise side effects when you switch from Mounjaro to Wegovy, maintain consistent injection timing, stay well-hydrated, and eat smaller, more frequent meals rich in fibre. Avoid high-fat foods during the first fortnight, as these can exacerbate nausea. If gastrointestinal symptoms persist beyond two weeks or significantly impact daily function, contact your prescriber—dose titration speed may need adjustment, or additional symptomatic management may be appropriate.

Treatment Active Ingredient Maintenance Dose Starting Price
Mounjaro Tirzepatide 5mg–15mg weekly From £145.00
Wegovy Semaglutide 2.4mg weekly From £199.00
Saxenda Liraglutide 3mg daily From £68.00
Wegovy Oral Tablet Semaglutide Daily tablet From £83.00

Cost Comparison: Switch From Mounjaro to Wegovy at Cured Pharmacy

Pricing considerations often influence the decision to switch from Mounjaro to Wegovy, particularly for patients funding treatment privately in the UK. At Cured Pharmacy, Mounjaro is available from £20 offering the most competitive tirzepatide pricing in the UK market. Wegovy starts from £124.99, reflecting the higher cost of semaglutide supply chains. Patients can Save £20 off their first order using code Weightlossnew, reducing the initial financial barrier when transitioning between medications.

Transparent upfront pricing at Cured Pharmacy ensures patients know the exact cost before completing their clinical consultation, with no hidden fees or subscription lock-ins. All doses from 0.25mg to 2.4mg for Wegovy, and 2.5mg to 15mg for Mounjaro, are available subject to prescriber approval following a free online assessment. Next-day delivery in discreet packaging is standard, ensuring continuity of treatment when switching from Mounjaro to Wegovy without interruption to your weight management programme.

Clinical Efficacy: Switch From Mounjaro to Wegovy Outcomes

Clinical trial data demonstrate robust efficacy for both medications, though head-to-head comparisons remain limited. The SURPASS-2 trial showed tirzepatide (Mounjaro) achieved superior weight loss compared to semaglutide 1mg in patients with type 2 diabetes, with 15mg tirzepatide producing 11.2kg average reduction versus 5.7kg for semaglutide[5]. However, Wegovy uses a higher 2.4mg semaglutide dose than studied in SURPASS-2, and the STEP trials showed this strength delivered 14.9% mean body weight reduction in adults without diabetes[2].

When patients switch from Mounjaro to Wegovy, the overall weight loss trajectory typically continues, though individual response varies. Some patients report equivalent or improved results on Wegovy, particularly if Mounjaro caused intolerable side effects that limited dose escalation. Others may experience a modest reduction in efficacy, especially if switching from higher Mounjaro doses (12.5mg or 15mg) to Wegovy 2.4mg. UK prescribers evaluate each case individually, considering prior weight loss percentage, current BMI, comorbidities, and patient preference when guiding the switch from Mounjaro to Wegovy to optimise long-term outcomes.

Long-Term Weight Maintenance After Switching

Sustaining weight loss after you switch from Mounjaro to Wegovy requires ongoing medication adherence combined with dietary and physical activity modifications. Both medications work by reducing appetite and slowing gastric emptying, but neither produces permanent metabolic changes—discontinuation typically results in weight regain. UK clinical guidelines recommend indefinite treatment for obesity management, with regular prescriber review every three to six months to assess continued benefit and tolerability when switching from Mounjaro to Wegovy or maintaining either therapy long-term.

How to Switch From Mounjaro to Wegovy Through Cured Pharmacy

Cured Pharmacy streamlines the process to switch from Mounjaro to Wegovy with a straightforward online clinical pathway. Begin by completing the free medical consultation questionnaire, which takes under three minutes and covers your current Mounjaro dose, weight loss progress, side effects, and medical history. A UK-registered prescriber reviews your submission, typically within 24 hours, and determines the appropriate Wegovy starting dose based on your tirzepatide treatment history and clinical response.

Once approved, your Wegovy prescription is dispensed by our GPhC-registered pharmacy (registration 9012511) under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073). Medication is dispatched via next-day delivery in 100% discreet packaging, with tracking provided. Ongoing prescriber support is included—if you experience any issues during the switch from Mounjaro to Wegovy, our clinical team is available via phone (+44 116 4646009) or secure messaging. Follow-up consultations ensure dose adjustments are made promptly to maintain safe, effective weight management throughout your transition and beyond.

Scientific References

  1. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  3. Medicines and Healthcare products Regulatory Agency. (2023). Summary of Product Characteristics: Wegovy 2.4mg solution for injection. MHRA UK. [accessed 15 August 2026]
  4. Smits, M. M., & Van Raalte, D. H. (2021). Safety of semaglutide. Frontiers in Endocrinology, 12, 645563. [accessed 15 August 2026]
  5. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I switch from Mounjaro to Wegovy immediately?
Most UK prescribers recommend waiting one week after your last Mounjaro dose before starting Wegovy to allow tirzepatide clearance and reduce the risk of overlapping GLP-1 effects.
Will I regain weight when I switch from Mounjaro to Wegovy?
Most patients maintain or continue weight loss when switching from Mounjaro to Wegovy, though a brief plateau during the first month is common as your body adjusts to semaglutide.
What Wegovy dose should I start on if I'm on Mounjaro 7.5mg?
Your UK prescriber will assess your individual response, but many patients transition from Mounjaro 7.5mg to Wegovy 1mg or 1.7mg depending on tolerability and weight loss achieved.
Is Wegovy cheaper than Mounjaro in the UK?
No—Mounjaro costs from £124.99 at Cured Pharmacy, whilst Wegovy starts from £124.99, making tirzepatide the more cost-effective option for many UK patients.
Do I need a new prescription to switch from Mounjaro to Wegovy?
Yes, Wegovy requires a separate prescription issued by a UK-registered prescriber following clinical assessment, which Cured Pharmacy provides free as part of the online consultation process.
Can I switch from Mounjaro to Wegovy if I have side effects?
Switching from Mounjaro to Wegovy may improve tolerability for some patients, though both medications share common GLP-1-related side effects—discuss your symptoms with a prescriber to determine the best approach.
How long does it take for Wegovy to work after switching from Mounjaro?
Most patients notice appetite suppression within one to two weeks when they switch from Mounjaro to Wegovy, with consistent weight loss resuming by week four as semaglutide reaches steady-state levels.
Will my NHS GP support my switch from Mounjaro to Wegovy?
NHS prescribing criteria for both medications are restrictive—many UK patients access Mounjaro and Wegovy privately through registered pharmacies like Cured Pharmacy, with full prescriber support for switching between treatments.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.